Two major cannabis developments illustrate how operators are preparing for a more complicated mix of federal oversight, international growth and consumer-market pressure. Tilray reported record quarterly revenue even as cannabis sales declined, Washington regulators advanced a new verification framework, and Spotify renewed one of the media industry’s most influential podcast partnerships.
Tilray Posts Record Revenue as Cannabis Sales Decline
Tilray Brands reported fiscal first-quarter net revenue of $257.1 million, an increase of 23% from the prior-year period, while gross profit rose 35% to $77.5 million. The company reaffirmed its fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million.
The headline growth was driven largely by Tilray’s expanding beverage portfolio. Beverage revenue increased 82% to $101.5 million following the BrewDog acquisition, while cannabis revenue declined to $56.1 million from $64.5 million. Tilray recorded a $40 million net loss and $9.2 million in adjusted EBITDA for the quarter.
Why It Matters: Analysis: The results demonstrate both the value and the limitations of diversification. Tilray is building a larger consumer-products platform capable of generating growth outside cannabis, but the contraction in cannabis revenue shows that scale in beverages does not automatically resolve pricing pressure and competitive challenges in the company’s original business.
Source: Tilray Brands
Washington Advances Medical Cannabis Verification Rules
The Washington State Liquor and Cannabis Board accepted a rulemaking petition seeking a formal process for documenting licensed businesses’ participation in state-authorized medical cannabis activities. The proposed system would allow retailers, producers and processors to request Medical Cannabis Verification Certificates based on state licensing and endorsement records.
The Cannabis Alliance argued that official documentation could help businesses seeking federal registration, research participation, insurance, banking services or other recognition tied to medical cannabis. Acceptance of the petition begins the rulemaking process; it does not mean the proposed certificate program has been adopted in its final form.
Why It Matters: Analysis: Washington’s integrated adult-use and medical market can make it difficult for operators to demonstrate that they conduct activities authorized under a state medical program. A workable verification system could become a model for other states attempting to align existing license structures with evolving federal requirements.
Source: MJBizDaily
Spotify Renews Joe Rogan With Multiyear Licensing Agreement
Spotify signed a new multiyear licensing agreement with Joe Rogan, extending a partnership that began in 2020. New episodes of The Joe Rogan Experience will continue to be available on Spotify and competing platforms rather than returning to an exclusive distribution model.
Spotify said the program has 18 million followers on its service. The company did not disclose the agreement’s financial terms.
Why It Matters: Analysis: The renewal reinforces Spotify’s strategy of retaining advertising and licensing relationships with major creators without requiring complete platform exclusivity. It also preserves a defining franchise for Spotify’s podcast business as video platforms increasingly compete for long-form interviews, commentary and creator-led programming.
Source: Spotify Newsroom
What We’re Watching
Over the next 24 to 72 hours, watch for investor reaction to Tilray’s revenue mix, details on Washington’s rulemaking timetable and any additional disclosures concerning Spotify’s renewed Rogan agreement. Cannabis regulators in other states may also signal whether they intend to create similar documentation for operators seeking recognition under changing federal rules.
